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ABSTRACT adb_335 887..896
A relatively small percentage of humans who are exposed to drugs of abuse eventually become addicted to or depen-
dent on those drugs. These individual differences in likelihood of developing drug addiction may reflect behavioral,
neurobiological or genetic correlates of drug addiction and are therefore important to model. Behavioral economic
measures of demand establish functions whose overall elasticity (rate of decrease in consumption as price increases)
reflects the reinforcing effectiveness of various stimuli, including drugs. Using these demand functions, we determined
the reinforcing effectiveness of five drugs of abuse (cocaine, remifentanil, ketamine, methohexital and ethanol) in 10
rhesus monkeys with histories of intravenous drug-taking. There was a continuum of reinforcing effectiveness across
the five drugs, with cocaine and remifentanil showing the most reinforcing effectiveness. There was also a continuum
of sensitivity of the monkeys; two of the 10 animals, in particular, showed greater demand for the drugs than did the
remaining eight monkeys. In addition, monkeys that demonstrated greater demand for one drug tended to show
greater demand for all drugs but did not show a similar relatively greater demand for sucrose pellets. These findings
suggest that the tendency to find drugs to be reinforcing is a general one, not restricted to particular drugs and also, that
a minority of animals show a substantially enhanced sensitivity to the reinforcing effects of drugs. The possibility that
differences in responsiveness to the reinforcing effects of drugs may form the basis of individual differences in drug-
taking in humans should be considered.
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effectiveness, rhesus monkeys.
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INTRODUCTION
One important aspect of drug addiction in humans is that
it occurs in a minority of individuals who engage in drug-
taking behavior. Anthony, Warner & Kessler (1994) sur-
veyed Americans between the ages of 15 and 54 and
reported that 75.6% of this population had tried tobacco,
and of these participants, 31.9% could be considered
dependent. A larger number, 91.5% of the population,
had tried alcohol, and 15.4% developed dependence.
Fewer individuals had tried cocaine (16.2%) or heroin
(1.5%), but a substantial percentage of users (16.7% and
23.1%, respectively) became dependent on these drugs.
Given that not all humans who try drugs become
addicted or dependent, it is worthwhile to attempt to
identify individual differences in drug taking by animals
that might reflect those differences in humans.
Research on individual differences in behavior, and
how these differences might relate to addiction proclivi-
ties, is currently gaining increasing attention, typically
using rats as subjects and stimulants as the drugs of
abuse. Some of the behaviors on which rats differed
were the degree of locomotion they engaged in when
exposed to a novel environment (Piazza et al. 1989,
1990), whether they responded more to a stimulus that
was paired with a reinforcer (sign tracking) or to the
place where the reinforcer was delivered (goal tracking)
(Flagel et al. 2008) and how impulsive they were in spe-
cific reaction time tasks (Belin et al. 2008). Each of these
behaviors was reflected in addiction-related outcomes.
For example, rats that showed more novelty-induced
locomotion acquired the ability to self-administer
amphetamine, whereas low responding rats did not
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showed somewhat more behavioral sensitization to
cocaine over seven days of drug administration than did
the goal-tracking rats (Flagel et al. 2008).
The reinforcing effects of drugs are fundamental
to the development of drug addiction and intrinsic
to most rodent models of addiction-like behavior. Never-
theless, individual differences in responsiveness to
drugs’ reinforcing effects are rarely investigated as
potential contributors to addiction. Studies of genetic
bases of addiction notwithstanding (e.g. Uhl 2006;
Osby et al. 2010), this question is difficult to approach in
the absence of a quantitative measure of the relative
reinforcing effectiveness of drugs (see Stephens et al.
2010 for review). Behavioral economic procedures
permit quantification of reinforcing effects, placing
a relative value on different drug reinforcers or on
individual differences in the reinforcing effect of the
same drug. This is done with demand curves, which
plot the amount of reinforcer consumed as a function
of the price (response requirement and dose) of the
drug. As long as doses are used that serve as reinforcers,
these curves are independent of the magnitude (dose) of
the reinforcer, allowing each reinforcing stimulus to be
given a single number that reflects its reinforcing effec-
tiveness: either the change in elasticity (slope) of the
demand curve as price increases or the point along the
increasing price axis where the most responses are made
(Pmax) (Hursh & Silberberg 2008). Relatively inelastic
demand curves and higher Pmax values indicate a rein-
forcer with more effectiveness than that indicated by
more elastic demand curves.
Demand curve analysis has the additional advantage
of permitting concentrated evaluation of relatively
few numbers of subjects as is often required in non-
human primate research. The use of demand curve
analysis to discern individual differences in the reinforc-
ing effects of drugs in these animals is potentially
instructive in attempts to identify idiosyncratic drug–
organism interactions that might eventually be applied
to human drug abuse issues. Among the questions
in the current study were whether the animals
showed individual differences in responsiveness to
the reinforcing effects of drugs, whether monkeys
that showed greater demand for one drug tended
to show greater demand for other drugs or whether
some monkeys have high demand for only one drug
and whether the tendency to show high demand
for a drug carried over to demand for non-drug
stimuli such as sucrose pellets or saline injections.
Comparisons were also made among animals with
respect to the amount of drug each self-administered
under the lowest price condition in order to ascertain




Subjects were 10 adult rhesus monkeys (Macaca mulatta),
eight males and two females (BU and HI). The monkeys
were fed high-protein monkey biscuits (LabDiet Fiber-
Plus, Brentwood, MO, USA) twice daily and fresh fruit or
vegetables once daily. Individual healthy adult body
weights, as determined by veterinary staff, were main-
tained and the monkeys were not systematically food-
deprived. Water was continuously available and novel
environmental enrichment was provided weekly. All
monkeys had a history of drug self-administration, and
the duration and extent of their histories is indicated in
Table 1.
The University of Michigan is accredited by the Ameri-
can Association for the Accreditation of Laboratory
Animal Care; procedures used in this experiment were
conducted in accordance with the National Research
Council’s (1996) Guide for the Care and Use of Labora-
tory Animals and approved by the University Committee
on Care and Use of Animals.
Apparatus
The monkeys were individually housed and tested in
stainless steel cages that measured 83.3 cm ¥ 76.2 cm ¥
91.4 cm. Each cage was equipped with a response panel
located on the left wall, approximately 10 cm from the
front and 19 cm from the bottom of the cage. The panel
contained three horizontally aligned levers that could be
activated by approximately 0.10–0.15 N of force. Three
stimulus lights, each of which was centered above a lever,
were 2.5 cm in diameter and spaced 1.5 cm apart. Each
light consisted of a circular opening that was covered with
translucent plastic and capable of being illuminated from
behind by 5-W colored bulbs. During the present study,
only one lever was active, and the light over that lever and
the center light were used.
Monkeys were implanted with indwelling intravenous
catheters (Murdock Industrial Inc, Akron, OH, USA) that
passed subcutaneously from the implanted veins to exit
sites on the monkeys’ backs. Each catheter was fed
through a stainless steel, flexible tether that was attached
to the back of the Teflon mesh jacket (Lomir, Notre-Dame-
de-l’Île Perrot, Quebec, Canada) worn by each monkey.
The other end of the tether was attached to the back wall
of the cage. Once the catheter exited the tether behind the
cage, it connected to a pump that was capable of infusing
the currently available drug into the catheter. The infu-
sion pump (Watson-Marlow model Sci-Q 400, Wilmin-
gon, MA, USA) delivered 0.2 ml of solution per second.
Each delivery lasted five seconds (totaling a 1-ml injection
volume). Control of experimental sessions was provided
888 Mikhail N. Koffarnus et al.
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by Med-PC (Med-Associates, Georgia, VT, USA), interfac-
ing and software installed on computers located in an
adjacent room.
Once all drugs and saline had been studied, demand
for 300 mg sucrose pellets was evaluated. The stimulus
lights and response levers were the same during testing
with sucrose pellets as they had been during testing of the
various drugs. A 43-cm square panel was added to the
housing cage, above and to the right of the stimulus light
and lever panel. This panel contained a food dispenser
(Model G5210, Gerbrands Corporation, Arlington, MA,
USA) on the outside and a pellet receptacle on the
monkeys’ side. Although nine of the 10 monkeys
responded readily for sucrose pellets without requiring
food deprivation, sucrose-maintained responding was not
stable in one monkey (SL) unless he was food-restricted
from 40 chows per day to 10 chows per day. He did not
lose weight during the one-month period his chow was
restricted.
Experimental procedures
The monkeys accessed the test drugs during two, 120-
minute sessions each day, which were approximately four
hours apart. Ethanol was an exception in that because it
has a fairly long duration of action; it was available
during only one 120-minute session each day. The begin-
ning of each session was indicated by the onset of the
rightmost, red stimulus light. In the presence of this light,
a predetermined number of responses on the right lever
caused the red light to be extinguished and a drug infu-
sion to be initiated. During the five-second drug infusion,
a green, center stimulus light was illuminated. Ethanol
was again an exception, with the concentration remain-
ing constant at 15% w/v, and the infusion duration
varying depending on the weight of the monkey. Follow-
ing the infusion, all stimulus lights were turned off
for 10 seconds, during which time responses had no pro-
grammed consequence. The red light was then illumi-
nated again, and responses were again effective in
producing a drug infusion.
The monkeys were required to make a fixed number of
responses to earn each drug injection in daily sessions.
The requirements were 10, 32, 100, 320, 562 and 1000
responses per injection. The ratio value remained con-
stant throughout a session, and each ratio value was in
effect for two consecutive sessions; the ratio sequence
across sessions was always ascending. Once a ratio of
1000 had been presented, the ratio value was reset to 10
and the series was repeated with another drug, saline or
finally, sucrose pellets.
Drugs
Five drugs (cocaine, remifentanil, methohexital, ket-
amine and ethanol) and saline were made available to the
monkeys. Cocaine was provided by the National Institute
on Drug Abuse (Bethesda, MD). Remifentanil was pur-
chased from the University of Michigan Hospital Phar-
macy. Methohexital and ketamine were purchased from
Henry Schein Animal Health (Melville, NY, USA, http://
www.henryschein.com). Ethanol was purchased from
Fisher Scientific (Rockford, IL, USA, http://www.
fishersci.com). The order of reinforcer presentation to the
different animals was non-systematic and is shown in
Table 2. All drugs were dissolved in sterile, normal saline.
All drugs except ethanol were delivered in a volume of
1 ml over five seconds in concentrations that varied
depending on the animals’ weights and the dose. Ethanol
was prepared as a 15% w/v solution; so for the 0.05 gm/
kg/injection dose used, the infusion volume of ethanol
was 1 ml per 3 kg of body weight (2.37 to 4.8 ml/
injection; 11.8 to 24 seconds infusion duration).
Table 2 The order that the five drugs and saline were presented to each monkey.
Drug presentation order
1 2 3 4 5 6
LU Remifentanil Saline Methohexital Ketamine Ethanol Cocaine
DA Methohexital Saline Ketamine Remifentanil Cocaine Ethanol
KO Methohexital Ketamine Saline Cocaine Remifentanil Ethanol
FR Remifentanil Methohexital Ethanol Ketamine Saline Cocaine
LE Methohexital Saline Remifentanil Ketamine Ethanol Cocaine
KR Saline Ketamine Methohexital Ethanol Remifentanil Cocaine
BU Methohexital Ketamine Ethanol Remifentanil Saline Cocaine
SL Methohexital Ketamine Cocaine Remifentanil Saline Ethanol
TI Ketamine Cocaine Methohexital Remifentanil Ethanol Saline
HI Methohexital Cocaine Saline Remifentanil Ethanol Ketamine
Sucrose pellets were always given following testing with all drugs.
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Because elasticity of demand functions is not modified
by dose of the commodity offered (Hursh & Winger
1995), single doses of each drug and a single sucrose
pellet size were evaluated. The doses (solution concentra-
tions in parentheses) were remifentanil 0.0001 mg/kg/
injection (0.00071 to 0.00144 mg/ml), ketamine
0.03 mg/kg/injection (0.213 to 0.432 mg/ml), metho-
hexital 0.1 mg/kg/injection (0.71 to 1.44 mg/ml) and
ethanol 0.05 gm/kg/injection (always 15% w/v).
Cocaine was available at a dose of 0.01 mg/kg/injection
(0.071 to 0.144 mg/ml) for all the monkeys except BU
and LE who, because they did not respond reliably at this
dose at larger ratio values, were evaluated at a dose of
0.03 mg/kg/injection (0.225 to 0.375 mg/ml).
Data analysis
The dependent variable of interest was the consumption
of each drug or the number of ratios completed during
the two-hour sessions of drug availability. Data obtained
from the two consecutive sessions at each fixed ratio (FR)
were averaged. These consumption data are expressed in
the form of demand curves throughout this article.
Normalized demand curves (Hursh & Winger 1995;
Hursh & Silberberg 2008) in which the point of origin on
the log–log curve was set equal to 100 were used to
compare elasticity of demand for the several drugs exam-
ined in this study. Consumption data were normalized to







where normalized consumption (Q) was equal to con-
sumption at FR n (Yn) divided by consumption at FR 10








where P is normalized price, FR is the FR value, and Y10 is
consumption at an FR 10. These normalized data were
then fit to the equation
log logQ Q k e aP= + −( )−0 1 (3)
where Q is reinforcer consumption at P price, Q0 is the
level of consumption as P approaches 0, and k and a are
fit parameters. Since data were normalized to a consump-
tion of 100, Q0 was set to 100 for all analyses. The a
parameter indicates the elasticity of the curve, or the rate
that consumption declines with increases in price, and
the k parameter represents the span of the function in
log10 units. A common span of k = 2.363 was used for all
analyses, which was experimentally derived by obtaining
the best fit curves to the mean data for saline, sucros
pellets and each drug in this article using GraphPad
Prism 5 (La Jolla, CA, USA). In this analysis, the a param-
eter was allowed to vary and a single shared k-value was
fit to all data sets. This left a single free parameter (a) that
quantified elasticity of demand, the proposed measure of
reinforcer effectiveness. The price that supported the most
overall responding was also computed. This value, Pmax,
was determined for each function by taking the first
derivative of equation 3 and evaluating at Y = -1 with a
equal to the fitted value for the curve of interest.
To compare correlations between two parameters that
were both subject to experimental variability, Pearson
product-moment correlations and Deming regressions
were conducted using GraphPad Prism 5. The distribu-
tion of Pmax values was not normal in the current experi-
ment so the values were log-transformed when used as
the basis of statistical comparisons. Standard scores for
log Pmax values and number of reinforcers earned at FR
10 were calculated by determining the number of stan-
dard deviations each subject’s value was from the mean
value of all subjects. This was done individually for each
drug and for saline and sucrose pellets.
RESULTS
As we have shown previously (Hursh & Winger 1995),
Pmax was largest (indicating relatively greater reinforcing
effectiveness) for cocaine and remifentanil and did not
differ between these two drugs (95% CI around Pmax over-
lapped; see bottom panel of Fig. 1). The Pmax values for
































Figure 1 Normalized demand for cocaine (), remifentanil
( ), methohexital (), ketamine (), ethanol (), saline () and
sucrose pellets (). Non-linear regression lines using equation 3 are
shown (Q0 was set to 100, k was a shared best-fit value common to
the entire data set and was equal to 2.363 and a was allowed to vary
for each reinforcer). Note that the regression lines for methohexital,
ketamine and sucrose pellets lie nearly on top of one another and
are difficult to distinguish.The Pmax ( 95% CI) values derived from
each curve are displayed in the bottom panel
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mately the same and each was less than those for
remifentanil and cocaine. Ethanol maintained a Pmax that
was larger than that maintained by saline but smaller
than that maintained by all other drugs and sucrose
pellets.
When evaluated for individual monkeys, only
remifentanil maintained a larger Pmax than did saline for
all 10 monkeys. As shown in Table 3, nine of the 10
monkeys showed a larger Pmax for cocaine than saline and
seven of 10 showed a larger Pmax for methohexital, ket-
amine, ethanol and sucrose pellets than for saline. One
monkey, LU, showed a significantly smaller Pmax (rela-
tively lower reinforcing effectiveness) for sucrose pellets
than for saline, and one monkey, BU, did not self-
administer any ethanol at any FR greater than FR 10,
preventing the calculation of demand parameters.
A continuum was evidenced in the demand of the
monkeys for the drugs (Fig. 2a). This was a general rather
than drug-selective effect, with the monkeys that showed
relatively greater reinforcing effectiveness of any one
drug also demonstrating relatively greater reinforcing
effectiveness for the other four drugs. The monkeys LU
and DA showed the largest Pmax for each of the drugs
relative to the other monkeys, whereas monkeys HI, TI
and SL had Pmax values that were consistently smaller
than average. Although the monkeys arranged them-
selves in a somewhat similar order when demand for
saline was calculated, this was not the case when demand
for sucrose pellets was determined. The standard devia-
tion scores for sucrose pellets did not conform to those
shown for the drugs.
The tendency for demand elasticity and therefore Pmax
to correlate across drugs of varying classes but not
sucrose pellets is shown in Fig. 3 and Table 4. When the
Pmax values obtained with individual subjects for each
drug were compared with the mean Pmax value of the
other drugs, positive correlations were the result in each
case. These correlations were statistically significant in
the case of cocaine, methohexital, ketamine and ethanol
(all P < 0.01). This correlation was positive for remifen-
tanil (r = 0.536) but not statistically significant with this
sample size. This underscores the finding that demand for
drugs appeared to be a trait-like phenomenon; the
monkeys that showed relatively greater reinforcing effec-
Table 3 Pmax values for each subject.
Cocaine Remifentanil Methohexital Ketamine Ethanol Saline Sucrose
LU 468.56*** 372.08*** 201.22** 173.88* 187.46* 95.24 46.25*
DA 308.26*** 544.15*** 251.88*** 186.70*** 89.68* 50.64 81.32
KO 235.82*** 267.87*** 134.81*** 138.37*** 55.83*** 15.55 182.85***
FR 201.22*** 272.33*** 118.45*** 148.93*** 59.39*** 7.97 90.10**
LE 100.13* 143.28*** 83.75*** 143.10*** 50.37*** 11.33 131.73***
KR 147.03*** 307.81*** 38.56 32.68 42.60** 15.94 116.95***
BU 194.26*** 217.76*** 76.26* 101.05** See text 40.45 112.28**
SL 172.84** 180.84** 32.65 44.86 32.07 19.38 91.43
TI 114.11 261.54* 19.57 26.59 31.34 24.36 271.34*
HI 98.33*** 122.03*** 52.51* 61.62** 46.78* 16.50 37.30*













































Reinforcers at FR 10

















Figure 2 The position of each subjects’ log Pmax values (a) and
reinforcers earned at an FR 10 (b) relative to the group mean of
values for each reinforcer. Number of standard deviations from the
mean is plotted on the ordinate for each measure, and points
represent each drug for each subject.The gray boxes surround the
range of values for the drugs only (filled symbols), and the gray bars
represent the mean of the drugs only. The open circles (saline)
and open squares (sucrose pellets) are displayed for comparison
purposes
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tiveness of one drug were also likely to show relatively
greater reinforcing effectiveness of the other drugs,
whereas the monkeys that showed relatively lesser rein-
forcing effectiveness of one drug were likely to show rela-
tively lesser reinforcing effectiveness of the other drugs.
The Pmax value for sucrose pellets was negatively but not
significantly correlated with the Pmax for the other five
drugs, suggesting, as shown earlier, that the demand for
drug was unlikely to reflect a general tendency to respond
more for reinforcers. The Pmax values obtained with saline
injections were positively correlated with the Pmax values
for the five drugs (r = 0.548), although this was not a
significant correlation.
Similar calculations were used to determine whether
these patterns would also be observed if reinforcers earned
at FR 10 were used as a metric of drug self-administration.
This was not the case. Individual subjects were unlikely to
consistently earn more or fewer reinforcers than the
average subject at an FR 10 (Fig. 2b). There were also no
significant correlations between the number of reinforc-
ers earned at an FR 10 for any of the drugs and these
values for other drugs (Table 4), with all Pearson’s r values
below 0.3 and none approaching statistical significance.
Saline injections and sucrose pellets earned also did not
correlate with reinforcers earned at an FR 10 for the five
drugs (Table 4). Therefore, intake at the single, low price
assessed at FR 10 did not offer the same resolving power to
characterize the patterns described earlier as did demand































































































Figure 3 Correlations between the Pmax
value obtained for each drug and the mean
Pmax value for the other drugs (a, b, d, e, g).
For example, the abscissa in panel a repre-
sents the Pmax value for cocaine for each
subject, and the ordinate represents the
mean Pmax value of remifentanil, methohexi-
tal, ketamine and ethanol. The correlations
between the Pmax value for sucrose pellets
(c) and saline (f) and the mean Pmax value
for all five drugs are also shown. Deming
regression lines and the Pearson r for each
correlation are displayed on the panel along
with the statistical significance of the corre-
lation coefficient (ns = not significant,
**P < 0.01, ***P < 0.001). Note the log10
axes
Table 4 Correlations between the Pmax values or reinforcers
earned at FR 10 for each drug and the average of the other
drugs.
Pmax Reinforcers at FR 10
Pearson’s r P value Pearson’s r P value
Cocaine -0.816 0.004 -0.030 0.935
Remifentanil 0.536 0.110 0.294 0.410
Methohexital 0.912 <0.001 0.287 0.421
Ketamine 0.792 0.006 0.184 0.611
Ethanol 0.871 0.002 -0.190 0.625
Saline 0.548 0.101 0.360 0.308
Sucrose pellets -0.344 0.331 -0.295 0.408
Correlations for cocaine, remifentanil, methohexital, ketamine and
ethanol are between the value for that drug and the mean value of the
other four drugs. Correlations for saline and sucrose pellets are between
the value for saline or sucrose pellets, respectively, and the mean value for
all five drugs.
Individual differences in monkeys’ drug-taking 893
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction Addiction Biology, 17, 887–896
DISCUSSION
In general, each of the five drugs served as reinforcers.
Cocaine and remifentanil were ranked as the most effec-
tive reinforcers among this series of drugs; similarly, rela-
tively inelastic demand for these two drugs has been
shown in other studies using rhesus monkeys (e.g. Wade-
Galuska, Winger & Woods 2007). Saline was the least
effective reinforcing stimulus, and sucrose, methohexital,
ketamine and ethanol fell between these two categories.
Other studies have also shown methohexital, ketamine
and ethanol to be relatively ineffective reinforcers com-
pared with cocaine or remifentanil (Hursh & Winger
1995; Winger, Galuska & Hursh 2007). Food is some-
times reported to have greater reinforcing effectiveness
than cocaine (e.g. Christensen et al. 2008a), while the
reverse was true in this set of monkeys for cocaine and
sucrose. This is likely due to the lack of a systematic food
deprivation protocol in the current study (see methods
section for description of the feeding protocol) as level of
extra session feeding is known to affect food versus
cocaine choice in monkeys (Nader & Woolverton 1992;
Negus 2003).
In addition to supporting earlier reports of differ-
ences among drugs with respect to their reinforcing
effectiveness, the data also indicate that the monkeys dif-
fered in their sensitivities to the reinforcing effects of
drugs. The monkeys that showed that one drug had
relatively low reinforcing effectiveness tended to show
that the other drugs also had relatively low reinforcing
effectiveness. Said another way, some of the monkeys
appeared to be very sensitive to the reinforcing effects of
drugs, and the other monkeys appeared to be less sensi-
tive to these effects. There was a continuum of general
drug demand among this sample of 10 animals. Two
monkeys (DA and LU) showed noticeably more inelastic
demand for all five of the active drugs. This is a similar
figure (20%) to the rates of drug dependence found for
many drugs in humans (Anthony et al. 1994) and for
rates of cocaine addiction-like behavior in rats (Belin
et al. 2008). These two monkeys also had the most
inelastic demand for saline, suggesting that they either
had a greater propensity to respond in general or that
the light previously paired with the drug, the sound of
the injection pump and sensations associated with an
i.v. drug injection had greater conditional reinforcing
effects for them. They were not systematically different
from the other monkeys in their responding for sucrose
pellets, indicating that their demand for the tested drugs
was not based on a generally increased demand for all
reinforcing stimuli.
The monkeys in this study had different histories of
exposure to drugs. Nearly all of these histories consisted
of the self-administration of moderate doses of drugs that
were available during twice daily, two-hour sessions (see
Table 1). Christensen et al. (2008b) showed that the rein-
forcing effectiveness of cocaine was enhanced with
increased exposure to cocaine. Several other studies in
rats have emphasized the importance of prolonged access
to drugs of abuse before individual differences in
addiction-like behaviors develop (Belin et al. 2008,
2009). In the current study, drug self-administration his-
tories, in terms of the amount of drug taken or the variety
of drugs taken, were not noticeably greater in the
monkeys that showed greater demand for drugs. It is
interesting to note, however, that the three monkeys that
had experience with self-administration of the D3-
preferring dopamine agonists pramipexole and quin-
pirole, as well as with the D2 agonist sumanirole, were
the monkeys that showed the most demand for the drugs
used in the current study. The exposure to the dopamine
agonists occurred in a study in which the reinforcing
effects of these drugs were evaluated in comparison with
cocaine. As can be determined from the table, LU and DA,
the monkeys showing the most demand for drugs, self-
administered substantial doses of the D3-preferring ago-
nists, whereas KO, the monkey that ranked just below LU
and DA in drug demand, did not demonstrate a reinforc-
ing effect of the dopamine agonists (Koffarnus, Collins &
Woods, unpublished data). This is provocative informa-
tion and among several issues that suggest future studies.
Determining demand for drugs in animals that are ini-
tially drug-naïve and subsequently, evaluating drug
demand throughout a series of specific drug exposures
will provide needed information about the contribution
that amount and duration of drug history make in the
development of individual differences in sensitivity to
the reinforcing effects of drugs. This can also answer the
question of whether exposure to specific drugs appears to
alter drug demand in some or all animals.
Anthony et al. (1994) surmised that the transition
from drug use to drug dependence in humans could be
impacted by the reinforcing effects of the drugs as well as
by other factors including relative availability, opportu-
nity to use, cost, social factors and individual vulnerabili-
ties related to drug use. In the current study, the factors of
availability, opportunity, cost and presumably, social
factors were held constant, leaving reinforcing effects
and individual vulnerability as the primary variables.
Although no attempt was made here to measure drug
dependence or drug addiction in these monkeys, and it is
not clear how this could be accomplished, the data nev-
ertheless strongly support the supposition of Anthony
et al. (1994) that differences in sensitivity to reinforcing
effects of the drugs may be a critical factor in the devel-
opment of drug abuse in humans.
There is support in the human literature for these find-
ings of a general rather than a specific responsiveness to
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drugs’ reinforcing effects. Recent epidemiological data
indicate that the primary drug of abuse at treatment
entry varies dramatically among regions of the United
States, suggesting that many drug users simply use what-
ever drugs are locally available (National Institute on
Drug Abuse 2010). In an earlier study of male twin pairs,
Tsuang et al. (1998) found that abuse of any particular
drug was associated with a substantial increase in the
likelihood of abusing every other type of drug. These
investigators found that genetic and environmental
factors both played a role in the shared vulnerability to
drug abuse. This finding raises another potential use of
the demand procedure—identifying specific phenotypes
for genetic studies. Although increasingly sophisticated
methods are being developed for evaluating genetic data,
assessing drug-abusing phenotypes remains an issue that
can require multiple determinations of drug use in sub-
stantial numbers of individuals (e.g. Johnson et al. 2008).
Demand functions have been frequently obtained in
humans (e.g. Greenwald 2008; MacKillop et al. 2009),
and these procedures could be used to place numerical
values (e.g. Pmax values) on the sensitivity of randomly
selected individuals to the reinforcing effects of drugs.
Applying these sensitivity measures to genome-wide
association data sets could dramatically sharpen the
ability to apply genetic information to the presence of or
likelihood of developing drug abuse.
An ongoing question has been whether use of some
‘softer’ drugs may lead individuals to eventual use of
‘harder’ drugs (e.g. Wagner & Anthony 2002). Rather
than serving as ‘gateway drugs’, use of these less rein-
forcing compounds may simply indicate enhanced
responsiveness of an individual to the reinforcing effects
of psychoactive drugs. Those who go on to develop addic-
tion to cocaine or heroin may have greater sensitivity to
the reinforcing effects of drugs in general than do people
who stop their use with alcohol or marijuana.
The findings that a small sample of rhesus monkeys
demonstrates a clear continuum of sensitivity to the rein-
forcing effects of drugs have several interesting implica-
tions about the basis of drug abuse, and assessing these
reinforcing effects with demand functions may provide an
effective technique for evaluating differential susceptibil-
ity to the reinforcing effects of drugs. Since these tech-
niques can be employed in both animal and human
populations, the cross-species relevance of findings can
be evaluated in the near future.
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